期刊文献+

布拉氏酵母菌联合左氧氟沙星治疗成人急性感染性腹泻临床疗效观察 被引量:18

The clinical observation on the effectiveness of saccharomyces boulardii plus levofloxacin in adult with acute infectious diarrhea
在线阅读 下载PDF
导出
摘要 目的观察布拉氏酵母菌联合左氧氟沙星治疗成人急性感染性腹泻的临床疗效。方法 120例成人急性腹泻者随机分为两组,治疗组采用布拉氏酵母菌联合左氧氟沙星治疗,共60例,对照组采用左氧氟沙星治疗,共60例。结果治疗组总有效率为96.67%,对照组为78.33%,两组比较差异有统计学意义(=9.22,P<0.05)。腹泻平均持续时间治疗组为(1.68±0.30)d,对照组为(2.13±0.35)d,两组比较差异有统计学意义(P<0.05);服药第3天,治疗组日平均大便次数为(1.48±0.14)次,对照组为(1.51±0.11)次(P>0.05),两组比较差异均无统计学意义。结论布拉氏酵母菌联合左氧氟沙星是成人急性腹泻的有效治疗手段,可以缩短成人急性腹泻的持续时间,改善腹泻症状。 Objective To assess the efficacy of Saccharomyces boulardii plus levofloxacin in adult with acute infection diarrhea.Methods 120 cases adults suffering from acute diarrhea were divided into 2 groups,Saccharomyces boulardii plus levofloxacin 60 cases,levofloxacin 60 cases.Results The total effective rate in the above groups were 96.67% and 81.67% respectively,comparison between the two groups showed significance(Х^2=9.22,P〈0.05);the mean diarrhea duration was(1.68±0.30)days in the treated group and(2.13±0.35) days in the controlled group,comparison between the two groups showed significance(P〈0.05);On the 3rd day,the patients in the treated group passed(1.48±0.14)stools/day versus(1.51±0.11) stools/day in controlled group(P〈0.05),comparison between the two groups showed nonsignificance.Conclusion Saccharomyces boulardii plus levofloxacin was effective for the treatment of acute infection diarrhea in adult,and it can decrease the duration of diarrhea,improve the acute diarrhea symptoms and reduced the risk of prolonged diarrhea.
作者 倪扬
机构地区 新津县人民医院
出处 《四川医学》 CAS 2011年第10期1600-1602,共3页 Sichuan Medical Journal
关键词 布拉氏酵母菌 左氧氟沙星 成人 感染性腹泻 saccharomyces boulardii levofloxacin adult infection diarrhea
  • 相关文献

参考文献11

  • 1方鹤松 魏承毓 段恕诚 等.腹泻病疗效判断标准的补充建议.中国实用儿科杂志,1998,13(6):384-384.
  • 2杨帆,焦红梅,张婴元,刘珂,张功芬.左氧氟沙星治疗细菌性感染70例[J].中国新药与临床杂志,1998,17(2):69-71. 被引量:56
  • 3McFarland LV,Bernasconi P.Saccharomyces boulardii:a review of an innovative biotherapeutic agent[J].Microb Ecol Health Dis,1993,6:151- 171.
  • 4Elmer GW,Surawicz CM,McFarland LV.Biotherapeutic agents.A neglected modality for the treatment and prevention of selected intestinal and vaginal secretions[J].JAMA,1996,275:870-876.
  • 5McFarland LV,SurAwicz CM,Greenberg RN.Prevention of b-lactam associated diarrhea by Saccharomyces boulardii compared with placebo[J].Am J Gastroenterol,1995,90:439-438.
  • 6Czerucka D,Roux J,Rampal P.Saccharomyces boulardii inhibits secretagogue-mediated adenosine 39,59-cyclic monophosphate induction in intestinal cells[J].Gastroenterology,1994,106(1):65-72.
  • 7Pothoulakis C,Kelly CP,Joshi MA.Saccharomyces boulardii inhibits Clostridium difficile toxin A and enterotoxicity in rat ileum[J].Gastroenterology,1993,103:1108- 1115.
  • 8Castagliulo I,Riegler MF,Valenick L,et al.Saccharomyces boularlii protease mediates Clostridium diflicile toxin A and B effects in human colonic mucosa[J].Infect Immun,1999,61:302-307.
  • 9Czerucka D,Dahan S,Mograbi B,et al.Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli infected T84cells[J].Infect Immun,2000,68:5998-6004.
  • 10Czerucka D,Dahan S,Mograbi B,et al.Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection[J].Infect Immun,2001,69:1298- 1305.

共引文献481

同被引文献105

引证文献18

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部